Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 1/2017

28.07.2016

Stroke etiologic subtype may influence the rate of hyperdense middle cerebral artery sign disappearance after intravenous thrombolysis

verfasst von: Stefano Forlivesi, Paolo Bovi, Giampaolo Tomelleri, Nicola Micheletti, Monica Carletti, Giuseppe Moretto, Manuel Cappellari

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Disappearance of hyperdense middle cerebral artery sign (HMCAS) on non-contrast brain computed tomography (CT) scan is a reliable sign of arterial recanalization after intravenous (IV) thrombolysis for ischemic stroke. We aimed to assess whether stroke etiologic subtype may influence the rate of HMCAS disappearance and the clinical outcome after IV thrombolysis. We conducted a retrospective analysis of data prospectively collected from 1031 consecutive stroke patients treated with IV thrombolysis. Outcome measures were HMCAS disappearance on follow-up CT scan within 22–36 h of IV thrombolysis, neurologic improvement (NIH Stroke Scale [NIHSS] ≤4 points from baseline or NIHSS score of 0) at 7 days, and modified rankin scale (mRS) ≤1 at 3 months. Of 256 patients with HMCAS on admission CT scan, 125 had a cardioembolic stroke, 67 a stroke due to large-artery atherosclerosis (LAA), 58 a stroke of undetermined etiology, and six a stroke secondary to carotid artery dissection. HMCAS disappearance occurred in 145 (56.6 %) patients, neurologic improvement in 122 (55.0 %) patients, and mRS ≤1 in 64 (32.8 %) patients. Compared with cardioembolic stroke patients, patients with stroke due to LAA had lower odds ratios (OR) for HMCAS disappearance (OR 0.29, 95 % CI 0.15–0.58, p < 0.001), neurologic improvement (OR 0.42, 95 % CI 0.22–0.82, p = 0.011), and mRS ≤1 (OR 0.18, 95 % CI 0.06–0.52, p = 0.002). No significant differences in outcome measures were found between cardioembolic strokes and strokes of undetermined etiology. This study suggests that stroke due to LAA is associated with lower rates of HMCAS disappearance, neurologic improvement, and mRS ≤1 after IV thrombolysis, compared with cardioembolic stroke.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Muir KW, Buchan A, von Kummer R, Rother J, Baron JC (2006) Imaging of acute stroke. Lancet Neurol 5:755–768CrossRefPubMed Muir KW, Buchan A, von Kummer R, Rother J, Baron JC (2006) Imaging of acute stroke. Lancet Neurol 5:755–768CrossRefPubMed
2.
Zurück zum Zitat Mair G, Boyd EV, Chappell FM et al (2015) Sensitivity and specificity of the hyperdense artery sign for arterial occlusion in acute ischemic stroke. Stroke 46:102–107CrossRefPubMed Mair G, Boyd EV, Chappell FM et al (2015) Sensitivity and specificity of the hyperdense artery sign for arterial occlusion in acute ischemic stroke. Stroke 46:102–107CrossRefPubMed
3.
Zurück zum Zitat Manelfe C, Larrue V, von Kummer R et al (1999) Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 30:769–772CrossRefPubMed Manelfe C, Larrue V, von Kummer R et al (1999) Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke 30:769–772CrossRefPubMed
4.
Zurück zum Zitat Kharitonova T, Ahmed N, Thorén M et al (2009) Hyperdense middle cerebral artery sign on admission CT scan: prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in stroke-international stroke thrombolysis register. Cerebrovasc Dis 27:51–59CrossRefPubMed Kharitonova T, Ahmed N, Thorén M et al (2009) Hyperdense middle cerebral artery sign on admission CT scan: prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in stroke-international stroke thrombolysis register. Cerebrovasc Dis 27:51–59CrossRefPubMed
5.
Zurück zum Zitat Kharitonova T, Thorén M, Ahmed N et al (2009) Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance. J Neurol Neurosurg Psychiatry 80:273–278CrossRefPubMed Kharitonova T, Thorén M, Ahmed N et al (2009) Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance. J Neurol Neurosurg Psychiatry 80:273–278CrossRefPubMed
6.
Zurück zum Zitat Mair G, von Kummer R, Morris Z et al (2016) Effect of alteplase on CT hyperdense artery sign and outcome after ischemic stroke. Neurology 86:118–125CrossRefPubMedPubMedCentral Mair G, von Kummer R, Morris Z et al (2016) Effect of alteplase on CT hyperdense artery sign and outcome after ischemic stroke. Neurology 86:118–125CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabín J (2004) Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 35:486–490CrossRefPubMed Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabín J (2004) Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke 35:486–490CrossRefPubMed
8.
Zurück zum Zitat Wahlgren N, Ahmed N, Dávalos A et al (2008) Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 372:1303–1309CrossRefPubMed Wahlgren N, Ahmed N, Dávalos A et al (2008) Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 372:1303–1309CrossRefPubMed
9.
Zurück zum Zitat Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24:35–41CrossRefPubMed Adams HP Jr, Bendixen BH, Kappelle LJ et al (1993) Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24:35–41CrossRefPubMed
10.
Zurück zum Zitat Kharitonova T, Mikulik R, Roine RO, Soinne L, Ahmed N, Wahlgren N (2011) Association of early National Institute of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke. Stroke 42:1638–1643CrossRefPubMed Kharitonova T, Mikulik R, Roine RO, Soinne L, Ahmed N, Wahlgren N (2011) Association of early National Institute of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke. Stroke 42:1638–1643CrossRefPubMed
11.
12.
Zurück zum Zitat Sato Y, Ishibashi-Ueda H, Iwakiri T et al (2012) Thrombus components in cardioembolic and atherothrombotic strokes. Thromb Res 130:278–280CrossRefPubMed Sato Y, Ishibashi-Ueda H, Iwakiri T et al (2012) Thrombus components in cardioembolic and atherothrombotic strokes. Thromb Res 130:278–280CrossRefPubMed
13.
Zurück zum Zitat Kim SK, Yoon W, Kim TS, Kim HS, Heo TW, Park MS (2015) Histologic analysis of retrieved clots in acute ischemic stroke: correlation with stroke etiology and gradient-echo MRI. AJNR Am J Neuroradiol 36:1756–1762CrossRefPubMed Kim SK, Yoon W, Kim TS, Kim HS, Heo TW, Park MS (2015) Histologic analysis of retrieved clots in acute ischemic stroke: correlation with stroke etiology and gradient-echo MRI. AJNR Am J Neuroradiol 36:1756–1762CrossRefPubMed
14.
Zurück zum Zitat Kirchhof K, Welzel T, Mecke C, Zoubaa S, Sartor K (2003) Differentiation of white, mixed and red thrombi: value of CT in estimation of the prognosis of thrombolysis—phantom study. Radiology 228:126–130CrossRefPubMed Kirchhof K, Welzel T, Mecke C, Zoubaa S, Sartor K (2003) Differentiation of white, mixed and red thrombi: value of CT in estimation of the prognosis of thrombolysis—phantom study. Radiology 228:126–130CrossRefPubMed
15.
Zurück zum Zitat Kim EY, Heo JH, Lee SK et al (2006) Prediction of thrombolytic efficacy in acute ischemic stroke using thin-section noncontrast CT. Neurology 67:1846–1848CrossRefPubMed Kim EY, Heo JH, Lee SK et al (2006) Prediction of thrombolytic efficacy in acute ischemic stroke using thin-section noncontrast CT. Neurology 67:1846–1848CrossRefPubMed
16.
Zurück zum Zitat Puig J, Pedraza S, Demchuk A et al (2012) Quantification of thrombus Hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 33:90–96CrossRefPubMed Puig J, Pedraza S, Demchuk A et al (2012) Quantification of thrombus Hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator. AJNR Am J Neuroradiol 33:90–96CrossRefPubMed
17.
Zurück zum Zitat Rubiera M, Ribo M, Delgado-Mederos R et al (2006) Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis. Stroke 37:2301–2305CrossRefPubMed Rubiera M, Ribo M, Delgado-Mederos R et al (2006) Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis. Stroke 37:2301–2305CrossRefPubMed
18.
Zurück zum Zitat Lau YC, Lane DA, Lip GY (2014) Atrial fibrillation in cryptogenic stroke: look harder, look longer, but just jeep looking. Stroke 45:3184–3185CrossRefPubMed Lau YC, Lane DA, Lip GY (2014) Atrial fibrillation in cryptogenic stroke: look harder, look longer, but just jeep looking. Stroke 45:3184–3185CrossRefPubMed
Metadaten
Titel
Stroke etiologic subtype may influence the rate of hyperdense middle cerebral artery sign disappearance after intravenous thrombolysis
verfasst von
Stefano Forlivesi
Paolo Bovi
Giampaolo Tomelleri
Nicola Micheletti
Monica Carletti
Giuseppe Moretto
Manuel Cappellari
Publikationsdatum
28.07.2016
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 1/2017
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-016-1404-x

Weitere Artikel der Ausgabe 1/2017

Journal of Thrombosis and Thrombolysis 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.